SIGA Technologies Logo
SIGA Announces BARDA Exercise of Contract Options Valued at $101.3 Million for the Procurement of Oral TPOXX®
April 29, 2020 16:30 ET | SIGA Technologies Inc.
Deliveries to Maintain National Security  Expected to Start in Second Quarter 2020      NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA Technologies Logo
SIGA Technologies to Host Business Update Call on May 6, 2020 after Release of First Quarter Financial Results
April 29, 2020 07:30 ET | SIGA Technologies Inc.
NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Technologies Logo
SIGA Announces Award of First International Contract for Oral TPOXX® with Purchase by the Canadian Department of National Defence
April 03, 2020 10:15 ET | SIGA Technologies Inc.
- Contract for up to $14.3 million for 15,325 Courses - NEW YORK, April 03, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused...
SIGA Technologies Logo
SIGA Technologies, Inc. Reports Financial Results for  Fiscal Year 2019
March 05, 2020 16:05 ET | SIGA Technologies Inc.
- Announces Expectations for Product Delivery to BARDA -- Announces $50 Million Share Repurchase Program -- Corporate Update Conference Call Today at 4:30 PM ET - NEW YORK, March 05, 2020 (GLOBE...
SIGA Technologies Logo
SIGA Announces Collaboration with Turnstone Biologics
March 02, 2020 16:30 ET | SIGA Technologies Inc.
SIGA to supply TPOXX® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program NEW YORK, March 02, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a...
SIGA Technologies Logo
SIGA to Host Business Update Call on March 5, 2020 after Release of Year End Financial Results
February 20, 2020 16:59 ET | SIGA Technologies Inc.
NEW YORK, Feb. 20, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...
SIGA Technologies Logo
SIGA Announces Canadian Department of National Defence Intent to Purchase Up To 15,325 Courses of Oral TPOXX®
December 05, 2019 12:10 ET | SIGA Technologies Inc.
Contract Would Represent First International Order of TPOXX Canadian Military Intends Firm Delivery of 2,500 Courses, with Additional Option Quantities of 12,825 Courses NEW YORK, Dec. 05, 2019 ...
SIGA Technologies Logo
SIGA Announces Canadian Release of the Advanced Contract Award Notice to Support Regulatory Filing for Oral TPOXX®
November 18, 2019 07:30 ET | SIGA Technologies Inc.
NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that the...
SIGA Technologies Logo
SIGA Technologies CEO to Speak at NCT Asia Conference on October 23, 2019
October 21, 2019 07:30 ET | SIGA Technologies Inc.
NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that Dr....
SIGA Technologies Logo
SIGA Completes Clinical Studies for IV Formulation of TPOXX®, NDA to be Submitted in 2020   
October 03, 2019 07:30 ET | SIGA Technologies Inc.
NEW YORK, Oct. 03, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it...